AMP Capital Investors Ltd lifted its position in shares of Aetna Inc. (NYSE:AET) by 3.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 216,076 shares of the company’s stock after acquiring an additional 7,202 shares during the quarter. AMP Capital Investors Ltd owned approximately 0.07% of Aetna worth $34,358,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Capital World Investors grew its stake in shares of Aetna by 8.9% during the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after acquiring an additional 1,688,767 shares during the period. FMR LLC grew its stake in shares of Aetna by 73.8% during the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after acquiring an additional 5,833,567 shares during the period. Janus Henderson Group PLC grew its stake in shares of Aetna by 9,446.2% during the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after acquiring an additional 4,283,553 shares during the period. UBS Asset Management Americas Inc. grew its stake in shares of Aetna by 7.5% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 2,553,496 shares of the company’s stock worth $387,697,000 after acquiring an additional 177,364 shares during the period. Finally, LSV Asset Management grew its stake in shares of Aetna by 8.7% during the 2nd quarter. LSV Asset Management now owns 2,467,782 shares of the company’s stock worth $374,683,000 after acquiring an additional 198,214 shares during the period. Institutional investors own 88.03% of the company’s stock.
AET has been the subject of several analyst reports. Credit Suisse Group restated a “neutral” rating and issued a $195.00 target price (up previously from $174.00) on shares of Aetna in a research note on Wednesday. Argus downgraded Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price for the company. in a research note on Wednesday. Wells Fargo & Company restated an “outperform” rating and issued a $208.00 target price (up previously from $200.00) on shares of Aetna in a research note on Monday. Piper Jaffray Companies restated a “hold” rating and issued a $187.00 target price on shares of Aetna in a research note on Friday, November 3rd. Finally, Raymond James Financial upgraded Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 target price for the company in a research note on Friday, November 3rd. Twelve analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $175.19.
Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.06 by $0.39. The firm had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company’s revenue for the quarter was down 5.0% on a year-over-year basis. During the same quarter last year, the company posted $2.07 EPS. sell-side analysts forecast that Aetna Inc. will post 9.78 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.12%. Aetna’s dividend payout ratio (DPR) is presently 37.04%.
In related news, President Karen S. Lynch sold 15,271 shares of the firm’s stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at $5,465,734.55. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “AMP Capital Investors Ltd Boosts Stake in Aetna Inc. (AET)” was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://www.chaffeybreeze.com/2017/12/07/amp-capital-investors-ltd-boosts-stake-in-aetna-inc-aet.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.